IRIS
MENZO, Stefano
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.043
EU - Europa 2.312
AS - Asia 860
SA - Sud America 138
AF - Africa 81
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 2
Totale 7.443
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.034
UA - Ucraina 462
IT - Italia 364
RU - Federazione Russa 296
IE - Irlanda 277
SG - Singapore 268
DE - Germania 240
HK - Hong Kong 204
SE - Svezia 195
DK - Danimarca 171
CN - Cina 167
BR - Brasile 123
FI - Finlandia 107
TR - Turchia 98
KR - Corea 91
GB - Regno Unito 73
FR - Francia 67
CI - Costa d'Avorio 57
MA - Marocco 20
NL - Olanda 18
BE - Belgio 16
IN - India 14
AT - Austria 13
AR - Argentina 6
CA - Canada 5
EU - Europa 5
IQ - Iraq 3
MX - Messico 3
PY - Paraguay 3
A1 - Anonimo 2
AE - Emirati Arabi Uniti 2
BO - Bolivia 2
CM - Camerun 2
CO - Colombia 2
CZ - Repubblica Ceca 2
HU - Ungheria 2
JP - Giappone 2
MK - Macedonia 2
NP - Nepal 2
PK - Pakistan 2
PL - Polonia 2
RO - Romania 2
AO - Angola 1
AU - Australia 1
BD - Bangladesh 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
EE - Estonia 1
HR - Croazia 1
KE - Kenya 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
RS - Serbia 1
TW - Taiwan 1
UY - Uruguay 1
UZ - Uzbekistan 1
Totale 7.443
Salva come PNG Salva come JPEG
Città #
Jacksonville 479
Chandler 441
Fairfield 376
Des Moines 303
Dublin 277
Boardman 246
Ashburn 236
Hong Kong 204
Wilmington 189
Woodbridge 165
Houston 153
Seattle 139
Ann Arbor 119
Singapore 119
New York 116
Lawrence 107
Princeton 107
San Mateo 107
Cambridge 100
Redmond 70
Abidjan 57
San Diego 52
Moscow 51
The Dalles 50
Ancona 41
Civitanova Marche 38
Centro 35
London 23
Turin 20
Beijing 18
Helsinki 18
Brussels 16
Marche 16
Shanghai 14
Wuhan 14
Guangzhou 12
Nuremberg 12
Washington 12
Appignano 11
Los Angeles 10
Norwalk 10
Hanover 9
Rome 9
Milan 8
Chicago 7
Cingoli 7
Falls Church 7
Pune 7
Rio de Janeiro 7
São Paulo 7
Monte San Pietrangeli 6
Amsterdam 5
Bari 5
Fayetteville 5
Montesilvano Marina 5
Mugnano di Napoli 5
Cagliari 4
Fano 4
Jinhua 4
Kilburn 4
Munich 4
Ottawa 4
Vienna 4
Chiswick 3
Delhi 3
Florence 3
Formigine 3
Jiaxing 3
Macerata 3
Pesaro 3
Senigallia 3
Tappahannock 3
Tolentino 3
Wuxi 3
Arco 2
Asunción 2
Barrinha 2
Belo Horizonte 2
Bologna 2
Campinas 2
Caserta 2
Catania 2
Cava De' Tirreni 2
Chengdu 2
Dallas 2
Dugenta 2
Duque de Caxias 2
Goiânia 2
Hortolândia 2
Hounslow 2
Ibicoara 2
Itajaí 2
Itapuranga 2
Köseköy 2
Mexico City 2
New Bedfont 2
Nova Iguaçu 2
Piracicaba 2
Porto 2
Quanzhou 2
Totale 4.795
Salva come PNG Salva come JPEG
Nome #
Antimicrobial Resistance: A Challenge for the Future 176
Evaluation of the Ion AmpliSeq SARS-CoV-2 Research Panel by Massive Parallel Sequencing 128
Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020 116
A clone of linezolid-resistant Staphylococcus epidermidis bearing the G2576T mutation is endemic in an Italian hospital 114
Molecular tracing of SARS-CoV-2 in Italy in the first three months of the epidemic 110
Competitive polymerase chain reaction and analysis of viral activity at the molecular level. 106
Absolute quantitation of viremia in human immunodeficiency virus infection by competitive reverse transcription and polymerase chain reaction. 105
Hepatitis E in a region of Italy: An emerging autochthonous infection? 105
Increase and diversity of carbapenemase-producing Escherichia coli isolates, Italy 103
Distribution and molecular analysis of mef(A)-containing elements in tetracycline-susceptible and -resistant Streptococcus pyogenes clinical isolates with efflux-mediated erythromycin resistance. 99
Tocilizumab in COVID-19 interstitial pneumonia 97
Clinicopathological features of primary cutaneous B-cell lymphomas from an academic regional hospital in central Italy: no evidence of Borrelia burgdorferi association 96
Analysis of the functional relationship between V3 loop and gp120 context with regard to human immunodeficiency virus coreceptor usage using naturally selected sequences and different viral backbones. 95
Molecular profile of human immunodeficiency virus type 1 infection in symptomless patients and in patients with AIDS. 93
Dynamics of molecular parameters of human immunodeficiency virus type 1 activity in vivo. 92
Quantification of the HIV-1 total reservoir in the peripheral blood of naïve and treated patients by a standardised method derived from a commercial HIV-1 RNA quantification assay. 92
A prognostic model for estimating the time to virologic failure in HIV-1 infected patients undergoing a new combination antiretroviral therapy regimen. 90
Trend of clinical vancomycin-resistant enterococci isolated in a regional Italian hospital from 2001 to 2018 90
A single-step DNA extraction procedure for the detection of serum hepatitis B virus sequences by the polymerase chain reaction. 88
Host-specific modulation of the selective constraints driving human immunodeficiency virus type 1 env gene evolution. 87
Declining prevalence of HIV-1 drug resistance in antiretroviral treatment-exposed individuals in Western Europe. 84
A large epidemic of hepatitis B in Serbia: an integrated model for outbreak investigations in healthcare settings 83
Locally acquired hepatitis E virus in Marche Italy: Clinical/laboratory features and outcome 83
Genotypic and phenotypic correlates of the HIV Type 1 env gene evolution in infected children with discordant response to antiretroviral therapy. 82
Molecular epidemiology and pathogenic potential of underdiagnosed human papillomavirus types 82
Detection of human immunodeficiency virus type 1 genomic RNA in plasma samples by reverse-transcription polymerase chain reaction. 80
Quantitative molecular methods in virology. 79
Resistance and replicative capacity of HIV-1 strains selected in vivo by long-term enfuvirtide treatment. 79
Trans-activation of epidermal growth factor receptor gene by the hepatitis B virus X-gene product. 78
Insulin-like growth factor 1 expression correlates with clinical outcome in K-RAS wild type colorectal cancer patients treated with cetuximab and irinotecan 78
First Detection of SARS-CoV-2 by Real-Time Reverse Transcriptase-Polymerase Chain Reaction Assay in Pleural Fluid 78
Processivity and drug-dependence of HIV-1 protease: determinants of viral fitness in variants resistant to protease inhibitors. 77
SARS-CoV-2 multi-variant rapid detector based on graphene transistor functionalized with an engineered dimeric ACE2 receptor 76
Quantitative PCR and RT-PCR in virology. 76
Evolution and predictors of HIV type-1 drug resistance in patients failing combination antiretroviral therapy in Italy. 76
Local Epidemics Gone Viral: Evolution and Diffusion of the Italian HIV-1 Recombinant Form CRF60_BC 76
Eritromicino-resistenza da efflusso in ceppi tetraciclino-sensibili (Tcs) e tetraciclino-resistenti (Tcr) di Streptococcus pyogenes. 75
Absence of neuroinvasive disease in a liver transplant recipient who acquired West Nile virus (WNV) infection from the organ donor and who received WNV antibodies prophylactically. 73
Prophylaxis of HCV reinfection and direct-acting antiviral agents during liver transplantation 73
Quantitative evaluation of the recombinant HIV-1 phenotype to protease inhibitors by a single-step strategy. 72
A novel procedure for quantitative polymerase chain reaction by coamplification of competitive templates. 70
Evolutionary trends of resistance mutational patterns of HBV reverse transcriptase over years (2002–2012) of different treatment regimens: The legacy of lamivudine/adefovir combination treatment 70
Vaginal micropapillary lesions are not related to human papillomavirus infection: in situ hybridization and polymerase chain reaction detection techniques 69
Rare mutations in a domain crucial for V3-loop structure prevail in replicating HIV from long-term non-progressors. 68
Molecular epidemiology and pathogenetic potential of underdiagnosed human papillomavirus types. 68
High prevalence of carbapenem-resistant Klebsiella pneumoniae ST307 recovered from faecal samples in an Italian hospital 68
Human case of autochthonous West Nile virus lineage 2 infection in Italy, September 2011. 67
Sequence analysis of the hepatitis B virus pre-C region in hepatocellular carcinoma [HCC] and nontumoral liver tissues from HCC patients. 66
Analisi della regione tet(O)-mef(A) in un elemento orf3-negativo di Streptococcus pyogenes. 66
Visceral fat inflammation and fat embolism are associated with lung's lipidic hyaline membranes in subjects with COVID-19 65
Rules-based HIV-1 genotypic resistance interpretation systems predict 8 week and 24 week virological antiretroviral treatment outcome and benefit from drug potency weighting. 64
Low-abundance drug resistance mutations: extending the HIV paradigm to hepatitis B virus. 64
42. Adenoviridae 64
A statistical model based on serological parameters for predicting occult HBV infection: implications for organ/ blood donations 64
Cluster analysis of antibiotic susceptibility patterns of clinical isolates as a tool in nosocomial infection surveillance. 63
Slow response to entecavir treatment in treatment-naive HBV patients is conditioned by immune response rather than by the presence or selection of refractory variants 63
POOR RESPONSE TO FIRST BNT162B2 SARS-COV-2 VACCINE DOSE IN RECIPIENTS OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANT 63
Clinical use of quantitative molecular methods in studying human immunodeficiency virus type 1 (HIV-1) infection 62
Genotype and phenotype patterns of human immunodeficiency virus type 1 resistance to enfuvirtide during long-term treatment. 62
Absence of HHV-6 and HHV-7 in cerebrospinal fluid in relapsing-remitting multiple sclerosis. 61
Long-term follow-up of acute hepatitis B: New insights in its natural history and implications for antiviral treatment 61
Human papillomavirus infections: new perspectives for prevention and treatment. 60
No pol mutation is associated independently with the lack of immune recovery in patients infected with HIV and failing antiretroviral therapy. 60
Italian Patent with european extension: New molecular vector for the geno-phenotypic characteristics of V3 sequences of the HIV gp120. 60
Evolutionary pattern of pandemic influenza (H1N1) 2009 virus in the late phases of the 2009 pandemic. 60
A human binding site for transcription factor USF/MLTF mimics the negative regulatory element of human immunodeficiency virus type 1. 59
European Patent n° EPO 99830776.3: Method to evaluate the HIV drug sensitivity 58
Inhibition of R5X4 dualtropic HIV-1 primary isolates by single chemokine co-receptor ligands. 58
Competitive polymerase chain reaction for quantitating feline immunodeficiency virus load in infected cat tissues. 57
Clearance of HIV-1 viraemia after seroconversion. 57
Immune reconstitution in HIV-1 infected children with discordant response to antiretroviral therapies: patterns of HIV-1 env gene evolution driven by restoration of thymic function. 56
Molecular and cellular determinants of cell-to-cell transmission of HCV in vitro. 56
Frequency and treatment-related predictors of thymidine-analogue mutation patterns in HIV-1 isolates after unsuccessful antiretroviral therapy. 56
Comparison of HIV-1 recombinant phenotypic assays and virtual phenotype in the definition of coreceptor usage 56
Circulating SARS-CoV-2 variants in Italy, October 2020–March 2021 56
Determinants of HIV-1 genotypic resistance to darunavir (TMC114) in a large Italian resistance database (Antiretroviral Resistance Cohort Analysis). 55
Prone Positioning and Intravenous Zanamivir may Represent Effective Alternatives for Patients with Severe ARDS Virus A (H1N1) Related Pneumonia in Hospitals with no Access to ECMO. 55
HIV-1 replication capacity and genotype changes in patients undergoing treatment interruption or lamivudine monotherapy. 55
Surgery and topic cidofovir for nasal squamous papillomatosis in HIV+ patient. 54
Simple and reliable method to quantify the hepatitis B viral load and replicative capacity in liver tissue and blood leukocytes 54
Detection of human immunodeficiency virus type 1 transcripts in peripheral blood lymphocytes by the polymerase chain reaction. 53
HPV DNA positivity and natural killer cell activity in the clinical outcome of mild cervical dysplasia: integration between virus and immune system 52
Lack of Chlamydia infection of the central nervous system in multiple sclerosis. 52
Lamivudine monotherapy in HIV-1-infected patients harbouring a lamivudine-resistant virus: a randomized pilot study (E-184V study). 51
Hemagglutinin 222 variants in pandemic (H1N1) 2009 virus. 51
Human immunodeficiency virus type 1 and hepatitis B virus transcription in peripheral blood lymphocytes from co-infected subjects. 51
Studies in subjects with long-term nonprogressive human immunodeficiency virus infection. 50
Direct detection of HBV preC mutants in heterogeneous viral populations by a modified DNA sequencing method. 50
PCR real time assays for the early detection of BKV-DNA in immunocompromised patients. 49
Identification of six putative novel human papillomaviruses (HPV) and characterization of candidate HPV type 87. 49
Quantitative molecular monitoring of human immunodeficiency virus type 1 activity during therapy with specific antiretroviral compounds 48
Quantitation of hepatitis C virus genome molecules in plasma samples. 48
Dynamics and modulation of human immunodeficiency virus type 1 transcripts in vitro and in vivo 47
The introduction of the fusion inhibitors in the HAART-regimens. 47
Hepatitis B virus preC mutants in human hepatocellular carcinoma tissues. 47
No evidence of association between Borrelia Burgdorferi and primary cutaneous B-cell lymphomas in Marche Region, in Italy. 46
Adeno-associated virus type 5 infection via PDGFRα is associated with Interstitial lung disease in systemic sclerosis and generates composite peptides and epitopes recognized by the agonistic immunoglobulins present in patients with systemic sclerosis 45
Lack of detectable human T-cell lymphotropic virus type I sequences in samples from multiple sclerosis patients. 45
Selected nucleotide sequence of the pol gene of the monocytotropic strain HIV type 1 BaL. 44
Comparison of levels of HIV-1 resistance to protease inhibitors by recombinant versus conventional virus phenotypic assay and two genotypic interpretation procedures in treatment-naive and HAART-experienced HIV-infected patients. 44
Totale 7.061
Salva come PNG Salva come JPEG
Categoria #
all - tutte 42.943
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.943
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020153 0 0 0 0 0 0 0 0 0 0 21 132
2020/20211.504 81 196 251 24 147 86 134 110 139 123 150 63
2021/2022882 83 211 13 24 10 53 56 58 67 58 68 181
2022/20231.545 136 116 124 113 117 393 10 72 330 6 99 29
2023/2024820 134 16 50 118 167 151 8 40 13 13 17 93
2024/20251.415 205 149 84 10 55 50 175 67 472 132 16 0
Totale 7.573